Étude comparative des résultats carcinologiques après prostatectomie et radiothérapie externe (75,6 Gy) avec hormonothérapie concomitante pour cancer de prostate à risque intermédiaire de D'Amico

According to our study, there was no superiority of the radical prostatectomy ± adjuvant treatment or the external radiotherapy combining high dose and concomitant short hormonotherapy on the survival without biological recurrence at 5 and 8 years. Many studies confirm that a concomitant hormonotherapy increases the carcinologic control, even with a high rate external beam radiotherapy.